Circular 33 of 2023: Prescribed Minimum Benefit definition guideline for inflammatory bowel disease (Ulcerative colitis and Crohn’s disease)
The Council for Medical Schemes (CMS) hereby informs stakeholders of the commencement of the process to develop Prescribed Minimum Benefit (PMB) definition guidelines for inflammatory bowel disease (ulcerative colitis and Crohn’s disease).
The CMS in its efforts to be an agile and transformative regulator to promote affordable and accessible healthcare cover towards universal health coverage, is putting efforts into the Benefit Definition Guidelines Project to clarify PMB entitlements and to offer guidance to all stakeholders in interpreting PMB provisions in terms of the relevant legislation.
The PMB definition guideline development process, is based on the best available evidence and clinical practice knowledge for the assessment and treatment of inflammatory bowel disease (IBD). Our recommendations will be compiled by technical experts, healthcare professionals and the medical schemes industry representatives.
Download the complete Circular here.